サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1441395

臨床試験イメージングの世界市場：規模・予測 - 製品・サービス別、モダリティ別、エンドユーザー別、地域別分析（2023年～2030年）

Global Clinical Trial Imaging Market Size study & Forecast, by Product and Service, by Modality, by End-User and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
臨床試験イメージングの世界市場：規模・予測 - 製品・サービス別、モダリティ別、エンドユーザー別、地域別分析（2023年～2030年）
出版日: 2024年02月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床試験イメージングの市場規模は、2022年に約11億3,000万米ドルに達し、予測期間2023年～2030年に5.38％超の健全な成長率で成長すると予測されています。 臨床試験イメージングとは、臨床試験中に新薬や医療機器などの医療介入の効果を評価・モニタリングするために、様々な画像技術やテクノロジーを使用することを指します。

これらの臨床試験は、被験者に対する介入の安全性と有効性を評価するために実施されます。臨床試験イメージング市場は、臨床試験の増加やCRO（医薬品開発業務受託機関）の増加などの要因により拡大しています。画像診断は、人体の解剖学、生理学、機能に関する詳細な視覚情報を提供することで、臨床試験において重要な役割を果たしています。その結果、2023年～2030年の予測期間中、国際市場では臨床試験イメージングに対する需要が徐々に増加しています。

規制機関は新たな医療介入を承認する上で重要な役割を担っており、画像データはこうした決定に寄与することが多いです。試験件数の増加は、より広範な規制当局の精査につながる可能性があり、画像データの取得、分析、報告に関するガイドラインを遵守することの重要性が強調されています。Statistaによると、米国以外の地域で登録された臨床試験の数は約24万2,000件であったのに対し、米国では14万1,000件以上でした。臨床試験イメージング市場を牽引するもう1つの重要な要因は、イメージング実施施設の選定、標準化されたイメージングプロトコルの導入、規制要件の遵守といったプロセスを効率化することで、臨床試験の効率的な開始を促進するCRO（医薬品開発業務受託機関）の増加です。このような効率化は、臨床試験全体のスケジュールにプラスの影響を与える可能性があります。また、Statistaによると、2023年のCROの世界市場規模は約770億米ドルで、2028年には1,273億米ドルに達すると予測されています。さらに、製薬会社やバイオテクノロジー企業における研究開発費の急増や、世界の医療費の増加は、予測期間中に市場に有利な成長機会をもたらすと予測されています。しかし、リスクの高い放射線による疾病や厳しい規制政策が、2023年～2030年の予測期間を通じて市場全体の成長を妨げる見通しです。

臨床試験イメージングの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、Charles River Laboratories International, Inc.、IQVIA Inc.などの主要アウトソーシング企業の存在と、同地域における研究開発活動の増加により、2022年の市場を独占しました。研究開発の取り組みは、疾病メカニズムや治療効果の理解を深めることにつながります。この知識により、特定の治療領域に合わせたカスタマイズされたイメージングプロトコルの開発が可能になり、臨床試験のイメージングの妥当性と効率が最適化されます。この地域の圧倒的な実績は、臨床試験イメージング全体の需要を促進すると予想されます。さらに、アジア太平洋は人口の急速な増加や研究開発活動の活発化などの要因により、予測期間中に最も急成長すると予想されています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の臨床試験イメージング市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 業界の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 世界の臨床試験イメージング市場力学

  • 臨床試験イメージング市場の影響分析（2020年～2030年）
    • 市場促進要因
      • 臨床試験数の増加
      • CRO（医薬品開発業務受託機関）の増加
    • 市場の課題
      • 疾患を引き起こす高リスク放射線
      • 厳しい規制政策
    • 市場機会
      • 製薬・バイオテクノロジー企業における研究開発費の急増
      • 世界のヘルスケア支出の増加

第4章 世界の臨床試験イメージング市場の産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターのファイブフォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 臨床試験イメージングの世界市場：製品・サービス別

  • 市場スナップショット
  • 臨床試験イメージングの世界市場：製品・サービス別、実績 - ポテンシャル分析
  • 臨床試験イメージングの世界市場：製品・サービス別、推定・予測（2020年～2030年）
  • 臨床試験イメージング市場：サブセグメント分析
    • 臨床試験デザインコンサルティングサービス
    • 読影分析サービス
    • オペレーショナル・イメージング・サービス
    • イメージングソフトウェア

第6章 臨床試験イメージングの世界市場：モダリティ別

  • 市場スナップショット
  • 臨床試験イメージングの世界市場：モダリティ別、実績 - ポテンシャル分析
  • 臨床試験イメージングの世界市場：モダリティ別、推定・予測（2020年～2030年）
  • 臨床試験イメージング市場：サブセグメント分析
    • 磁気共鳴イメージング
    • コンピュータ断層撮影
    • 超音波
    • ポジトロン断層撮影
    • X線
    • 心エコー
    • その他のモダリティ

第7章 臨床試験イメージングの世界市場：エンドユーザー別

  • 市場スナップショット
  • 臨床試験イメージングの世界市場：エンドユーザー別、実績 - ポテンシャル分析
  • 臨床試験イメージングの世界市場：エンドユーザー別、推定・予測（2020年～2030年）
  • 臨床試験イメージング市場：サブセグメント分析
    • 製薬・バイオテクノロジー企業
    • 医療機器メーカー
    • 学術・政府研究機関

第8章 臨床試験イメージングの世界市場：地域分析

  • 主要国
  • 主要新興国
  • 臨床試験イメージング市場：地域市場スナップショット
  • 北米
    • 米国
      • 製品・サービスの推定・予測（2020年～2030年）
      • モダリティの推定・予測（2020年～2030年）
      • エンドユーザーの推定・予測（2020年～2030年）
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東・アフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • IXICO plc
    • Navitas Life Sciences
    • Resonance Health Ltd
    • ProScan Imaging
    • Radiant Sage LLC
    • Medpace Holdings, Inc
    • Biomedical Systems Corp
    • Cardiovascular Imaging Technologies
    • Intrinsic Imaging LLC
    • BioTelemetry, Inc

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Clinical Trial Imaging Market, report scope
  • TABLE 2. Global Clinical Trial Imaging Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Clinical Trial Imaging Market estimates & forecasts by Product and Service 2020-2030 (USD Billion)
  • TABLE 4. Global Clinical Trial Imaging Market estimates & forecasts by Modality 2020-2030 (USD Billion)
  • TABLE 5. Global Clinical Trial Imaging Market estimates & forecasts by End-User 2020-2030 (USD Billion)
  • TABLE 6. Global Clinical Trial Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Clinical Trial Imaging Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Clinical Trial Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Clinical Trial Imaging Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Clinical Trial Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Clinical Trial Imaging Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Clinical Trial Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Clinical Trial Imaging Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Clinical Trial Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Clinical Trial Imaging Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Clinical Trial Imaging Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Clinical Trial Imaging Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Clinical Trial Imaging Market
  • TABLE 71. List of primary sources, used in the study of global Clinical Trial Imaging Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Clinical Trial Imaging Market, research methodology
  • FIG 2. Global Clinical Trial Imaging Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Clinical Trial Imaging Market, key trends 2022
  • FIG 5. Global Clinical Trial Imaging Market, growth prospects 2023-2030
  • FIG 6. Global Clinical Trial Imaging Market, porters 5 force model
  • FIG 7. Global Clinical Trial Imaging Market, pest analysis
  • FIG 8. Global Clinical Trial Imaging Market, value chain analysis
  • FIG 9. Global Clinical Trial Imaging Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Clinical Trial Imaging Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Clinical Trial Imaging Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Clinical Trial Imaging Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Clinical Trial Imaging Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Clinical Trial Imaging Market, regional snapshot 2020 & 2030
  • FIG 15. North America Clinical Trial Imaging Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Clinical Trial Imaging Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Clinical Trial Imaging Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Clinical Trial Imaging Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Clinical Trial Imaging Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Clinical Trial Imaging Market is valued at approximately USD 1.13 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.38% during the forecast period 2023-2030. Clinical Trial Imaging refers to the use of various imaging techniques and technologies to assess and monitor the effects of a medical intervention, such as a new drug or medical device, during a clinical trial. These trials are conducted to evaluate the safety and efficacy of the intervention in human subjects. The Clinical Trial Imaging Market is expanding because of factors such as the increasing number of clinical trials and the growing number of Contract Research Organizations (CROs). Imaging plays a crucial role in clinical trials by providing detailed visual information about the anatomy, physiology, and function of the human body. As a result, the demand for Clinical Trial Imaging has progressively increased in the international market during the forecast period 2023-2030.

Regulatory bodies play a crucial role in approving new medical interventions, and imaging data often contribute to these decisions. The increasing number of trials could lead to more extensive regulatory scrutiny, emphasizing the importance of adhering to guidelines for imaging data acquisition, analysis, and reporting. According to Statista, the number of registered clinical studies in non-U.S. areas was approximately 242 thousand, whereas the number in the United States was more than 141 thousand. Another important factor that drives the Clinical Trial Imaging Market is the increasing number of Contract Research Organizations (CROs) that can facilitate the efficient start-up of clinical trials by streamlining the process of selecting imaging sites, implementing standardized imaging protocols, and ensuring compliance with regulatory requirements. This efficiency can positively impact the overall timeline of the clinical trial. In addition, as per Statista, in 2023, the anticipated global market size for Contract Research Organizations (CROs) accounts for approximately USD 77 billion worldwide and is projected to reach up to USD 127.3 billion by the year 2028. Moreover, the surge in R&D expenditure in pharmaceutical and biotechnological companies and rising healthcare expenditure across the world are anticipated to create lucrative growth opportunities for the market over the forecast period. However, high-risk Radiation Causing Diseases and stringent regulatory policies are going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Clinical Trial Imaging Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of major outsourcing companies such as Charles River Laboratories International, Inc., IQVIA Inc., and so on along with the increasing number of research and development activities in the region. R&D initiatives lead to a better understanding of disease mechanisms and treatment effects. This knowledge allows for the development of customized imaging protocols tailored to specific therapeutic areas, optimizing the relevance and efficiency of clinical trial imaging. The region's dominant performance is anticipated to propel the overall demand for Clinical Trial Imaging. Furthermore, Asia Pacific is expected to grow fastest over the forecast period, owing to factors such as rapid growth of the population, and increased research and development activities in the region.

Major market player included in this report are:

  • IXICO plc
  • Navitas Life Sciences
  • Resonance Health Ltd
  • ProScan Imaging
  • Radiant Sage LLC
  • Medpace Holdings, Inc.
  • Biomedical Systems Corp
  • Cardiovascular Imaging Technologies
  • Intrinsic Imaging LLC
  • BioTelemetry Inc

Recent Developments in the Market:

  • In September 2023, Mayo Clinic and GE HealthCare unveiled a strategic alliance in healthcare, focusing on collaborative research and product development initiatives. This partnership is designed to revolutionize the interactions between patients and healthcare professionals within radiology practices and the administration of innovative therapies. Named the Strategic Collaboration for Innovation in Medical Imaging and Theranostics, this initiative brings together a team of experts from Mayo Clinic and GE HealthCare, including scientists, technology developers, clinicians, and other healthcare providers. The primary objective of this collaboration is to empower clinicians with advanced technology for precise diagnosis and treatment of medical conditions. Additionally, the partnership aims to enhance the patient experience by integrating novel technologies and approaches to medical imaging and theranostics, thereby personalizing each phase of the patient's care journey.

Global Clinical Trial Imaging Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Product and Service, Modality, End-User, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product and Service

  • Trial Design Consulting Services
  • Read Analysis Services
  • Operational Imaging Services
  • Imaging Software

By Modality

  • Magnetic Resonance Imaging
  • Computed Tomography
  • Ultrasound
  • Positron Emission Tomography
  • X-Ray
  • Echocardiography
  • Other Modalities

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Manufacturers
  • Academic and Government Research Institutes

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Clinical Trial Imaging Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Clinical Trial Imaging Market, by Product and Service, 2020-2030 (USD Billion)
    • 1.2.3. Clinical Trial Imaging Market, by Modality, 2020-2030 (USD Billion)
    • 1.2.4. Clinical Trial Imaging Market, by End-User, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Clinical Trial Imaging Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Clinical Trial Imaging Market Dynamics

  • 3.1. Clinical Trial Imaging Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing number of clinical trials
      • 3.1.1.2. Growing number of Contract Research Organizations (CROs)
    • 3.1.2. Market Challenges
      • 3.1.2.1. High-Risk Radiation Causing Diseases
      • 3.1.2.2. Stringent Regulatory Policies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Surge in R&D expenditure in pharmaceutical and biotechnological companies
      • 3.1.3.2. Rise in Healthcare Expenditure across the world

Chapter 4. Global Clinical Trial Imaging Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Clinical Trial Imaging Market, by Product and Service

  • 5.1. Market Snapshot
  • 5.2. Global Clinical Trial Imaging Market by Product and Service, Performance - Potential Analysis
  • 5.3. Global Clinical Trial Imaging Market Estimates & Forecasts by Product and Service 2020-2030 (USD Billion)
  • 5.4. Clinical Trial Imaging Market, Sub Segment Analysis
    • 5.4.1. Trial Design Consulting Services
    • 5.4.2. Read Analysis Services
    • 5.4.3. Operational Imaging Services
    • 5.4.4. Imaging Software

Chapter 6. Global Clinical Trial Imaging Market, by Modality

  • 6.1. Market Snapshot
  • 6.2. Global Clinical Trial Imaging Market by Modality, Performance - Potential Analysis
  • 6.3. Global Clinical Trial Imaging Market Estimates & Forecasts by Modality 2020-2030 (USD Billion)
  • 6.4. Clinical Trial Imaging Market, Sub Segment Analysis
    • 6.4.1. Magnetic Resonance Imaging
    • 6.4.2. Computed Tomography
    • 6.4.3. Ultrasound
    • 6.4.4. Positron Emission Tomography
    • 6.4.5. X-Ray
    • 6.4.6. Echocardiography
    • 6.4.7. Other Modalities

Chapter 7. Global Clinical Trial Imaging Market, by End-User

  • 7.1. Market Snapshot
  • 7.2. Global Clinical Trial Imaging Market by End-User, Performance - Potential Analysis
  • 7.3. Global Clinical Trial Imaging Market Estimates & Forecasts by End-User 2020-2030 (USD Billion)
  • 7.4. Clinical Trial Imaging Market, Sub Segment Analysis
    • 7.4.1. Pharmaceutical & Biotechnology Companies
    • 7.4.2. Medical Device Manufacturers
    • 7.4.3. Academic and Government Research Institutes

Chapter 8. Global Clinical Trial Imaging Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Clinical Trial Imaging Market, Regional Market Snapshot
  • 8.4. North America Clinical Trial Imaging Market
    • 8.4.1. U.S. Clinical Trial Imaging Market
      • 8.4.1.1. Product and Service breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Modality breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End-User breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Clinical Trial Imaging Market
  • 8.5. Europe Clinical Trial Imaging Market Snapshot
    • 8.5.1. U.K. Clinical Trial Imaging Market
    • 8.5.2. Germany Clinical Trial Imaging Market
    • 8.5.3. France Clinical Trial Imaging Market
    • 8.5.4. Spain Clinical Trial Imaging Market
    • 8.5.5. Italy Clinical Trial Imaging Market
    • 8.5.6. Rest of Europe Clinical Trial Imaging Market
  • 8.6. Asia-Pacific Clinical Trial Imaging Market Snapshot
    • 8.6.1. China Clinical Trial Imaging Market
    • 8.6.2. India Clinical Trial Imaging Market
    • 8.6.3. Japan Clinical Trial Imaging Market
    • 8.6.4. Australia Clinical Trial Imaging Market
    • 8.6.5. South Korea Clinical Trial Imaging Market
    • 8.6.6. Rest of Asia Pacific Clinical Trial Imaging Market
  • 8.7. Latin America Clinical Trial Imaging Market Snapshot
    • 8.7.1. Brazil Clinical Trial Imaging Market
    • 8.7.2. Mexico Clinical Trial Imaging Market
  • 8.8. Middle East & Africa Clinical Trial Imaging Market
    • 8.8.1. Saudi Arabia Clinical Trial Imaging Market
    • 8.8.2. South Africa Clinical Trial Imaging Market
    • 8.8.3. Rest of Middle East & Africa Clinical Trial Imaging Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. IXICO plc
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Navitas Life Sciences
    • 9.3.3. Resonance Health Ltd
    • 9.3.4. ProScan Imaging
    • 9.3.5. Radiant Sage LLC
    • 9.3.6. Medpace Holdings, Inc
    • 9.3.7. Biomedical Systems Corp
    • 9.3.8. Cardiovascular Imaging Technologies
    • 9.3.9. Intrinsic Imaging LLC
    • 9.3.10. BioTelemetry, Inc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption